Skip to main content

Biotech stocks are set up to rally double-digits back to all-time highs, chart suggests

The Nasdaq biotech ETF could surge another 10% and break through its all-time highs, based on a positively trending chart and analysis by Miller Tabak's Matt Maley.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.